RNA-inhibiting small molecules for cancer (Arrakis Therapeutics)

N/A

Report date: 2025/01/26 17:03:41
NME

Base Information

Drug NameRNA-inhibiting small molecules for cancer (Arrakis Therapeutics)
Drug Alias NameMYC translation inhibitors (Arrakis)RNA-targeted small molecules for cancer (Arrakis Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyc proto-oncogene protein inhibitorsRNA modulators
TargetsRibonucleic AcidMyc proto-oncogene protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArrakis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesArrakis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A